Denise M Adams

Summary

Affiliation: Cincinnati Children's Hospital Medical Center
Country: USA

Publications

  1. pmc Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
    Denise M Adams
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio Boston Children s Hospital and Harvard Medical School, Boston, Massachusetts
    Pediatrics 137:e20153257. 2016
  2. doi request reprint Other vascular tumors
    Denise M Adams
    Cancer and Blood Disease Institute, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio Hemangioma and Vascular Malformation Center, Cincinnati Children s Hospital Medical Center, 3333 Burnett Ave, Cincinnati, Ohio, 45229 Electronic address
    Semin Pediatr Surg 23:173-7. 2014
  3. ncbi request reprint Cervicofacial vascular anomalies. I. Hemangiomas and other benign vascular tumors
    Denise M Adams
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, Cincinnati, Ohio 45229, USA
    Semin Pediatr Surg 15:124-32. 2006
  4. ncbi request reprint Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study
    Denise M Adams
    Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA
    Pediatr Blood Cancer 50:549-53. 2008
  5. doi request reprint The role of the hematologist/oncologist in the care of patients with vascular anomalies
    Denise M Adams
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, MLC 7015, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Pediatr Clin North Am 55:339-55, viii. 2008
  6. doi request reprint Special considerations in vascular anomalies: hematologic management
    Denise M Adams
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229, USA
    Clin Plast Surg 38:153-60. 2011
  7. doi request reprint Infantile hemangiomas with unusually prolonged growth phase: a case series
    Heather A Brandling-Bennett
    Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
    Arch Dermatol 144:1632-7. 2008
  8. doi request reprint Sirolimus for the treatment of complicated vascular anomalies in children
    Adrienne M Hammill
    Hemangioma and Vascular Malformation Center, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, USA
    Pediatr Blood Cancer 57:1018-24. 2011
  9. doi request reprint 2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: Radiologic-Pathologic Update
    Arnold C Merrow
    From the Department of Radiology A C M, M N P and Department of Pediatrics, Division of Pathology and Laboratory Medicine A G, Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, MLC 5031, Cincinnati, OH 45229 and Vascular Anomalies Center, Boston Children s Hospital, Boston, Mass D M A
    Radiographics 36:1494-516. 2016
  10. doi request reprint Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment
    Ralph Salloum
    Division of Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio
    Pediatr Blood Cancer 63:1911-4. 2016

Collaborators

Detail Information

Publications17

  1. pmc Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
    Denise M Adams
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio Boston Children s Hospital and Harvard Medical School, Boston, Massachusetts
    Pediatrics 137:e20153257. 2016
    ..This Phase II trial enrolled patients with complicated vascular anomalies to determine the efficacy and safety of treatment with sirolimus for 12 courses; each course was defined as 28 days...
  2. doi request reprint Other vascular tumors
    Denise M Adams
    Cancer and Blood Disease Institute, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio Hemangioma and Vascular Malformation Center, Cincinnati Children s Hospital Medical Center, 3333 Burnett Ave, Cincinnati, Ohio, 45229 Electronic address
    Semin Pediatr Surg 23:173-7. 2014
    ..These tumors are treated with multimodality therapy and therefore need the guidance of an interdisciplinary team for best care. ..
  3. ncbi request reprint Cervicofacial vascular anomalies. I. Hemangiomas and other benign vascular tumors
    Denise M Adams
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, Cincinnati, Ohio 45229, USA
    Semin Pediatr Surg 15:124-32. 2006
    ..This article presents an overview of hemangiomas and other vascular tumors, highlighting cervicofacial lesions and describing critical and underappreciated clinical presentations...
  4. ncbi request reprint Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study
    Denise M Adams
    Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA
    Pediatr Blood Cancer 50:549-53. 2008
    ....
  5. doi request reprint The role of the hematologist/oncologist in the care of patients with vascular anomalies
    Denise M Adams
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, MLC 7015, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Pediatr Clin North Am 55:339-55, viii. 2008
    ..They provide the clinical and medical skills needed to diagnose, treat, and manage these patients. Hematologist/oncologists also provide support for clinical trials and drug development to further treatment options for these patients...
  6. doi request reprint Special considerations in vascular anomalies: hematologic management
    Denise M Adams
    Division of Hematology Oncology, Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229, USA
    Clin Plast Surg 38:153-60. 2011
    ..These patients can have complicated coagulopathies and need medical therapy. This article emphasizes the hematologic complications and management of these patients...
  7. doi request reprint Infantile hemangiomas with unusually prolonged growth phase: a case series
    Heather A Brandling-Bennett
    Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
    Arch Dermatol 144:1632-7. 2008
    ..We performed a retrospective case series of IHs with prolonged growth to further characterize these lesions and their treatment...
  8. doi request reprint Sirolimus for the treatment of complicated vascular anomalies in children
    Adrienne M Hammill
    Hemangioma and Vascular Malformation Center, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, USA
    Pediatr Blood Cancer 57:1018-24. 2011
    ..Vascular tumors such as kaposiform hemangioendotheliomas (KHE) and complicated vascular malformations have proven particularly difficult to treat...
  9. doi request reprint 2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: Radiologic-Pathologic Update
    Arnold C Merrow
    From the Department of Radiology A C M, M N P and Department of Pediatrics, Division of Pathology and Laboratory Medicine A G, Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, MLC 5031, Cincinnati, OH 45229 and Vascular Anomalies Center, Boston Children s Hospital, Boston, Mass D M A
    Radiographics 36:1494-516. 2016
    ..The known clinical courses and imaging, histologic, and genetic findings of the most common and/or clinically relevant lesions in the newly adopted revised system are reviewed in this article. (©)RSNA, 2016. ..
  10. doi request reprint Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment
    Ralph Salloum
    Division of Oncology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio
    Pediatr Blood Cancer 63:1911-4. 2016
    ..Traditional treatment modalities include corticosteroids, interferon-α, sclerotherapy, and aggressive surgical resection. Sirolimus has been used in several single case reports...
  11. ncbi request reprint Angiopoietins as serum biomarkers for lymphatic anomalies
    Timothy D Le Cras
    Division of Pulmonary Biology, Department of Pediatrics, Cincinnati Children s Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, Cincinnati, OH, 45229 3039, USA
    Angiogenesis . 2016
    ..Hence, serum Ang-2 and Ang-1 levels may help in the diagnosis of patients with lymphatic anomalies and are concordant to sirolimus response...
  12. pmc Infantile hemangioma status by dynamic infrared thermography: A preliminary study
    Shoná A Burkes
    Skin Sciences Program, University of Cincinnati, Cincinnati, OH, USA
    Int J Dermatol 55:e522-32. 2016
    ..Objective quantitative evaluation of IH treatment response is essential for improving outcomes. We applied a functional imaging method, dynamic infrared (IR) thermography, to investigate IH status versus control skin and over time...
  13. doi request reprint Long-term outcome for kaposiform hemangioendothelioma: A report of two cases
    Beverly A Schaefer
    Cancer and Blood Disease Institute, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio
    Pediatr Blood Cancer 64:284-286. 2017
    ..We report two young women who had KHE with KMP treated in infancy and presented in adolescence with comorbidities related to their KHE tumor. This presentation supports the need for long-term surveillance in these patients...
  14. doi request reprint Imaging evaluation of fetal vascular anomalies
    Maria A Calvo-Garcia
    Department of Radiology, MLC 5031 Cincinnati Children s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229 3039, USA
    Pediatr Radiol 45:1218-29. 2015
    ..Concordance between prenatal and postnatal diagnoses is analyzed, with further discussion regarding potential pitfalls in identification. ..
  15. doi request reprint Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH)
    Michael F Fadell
    Department of Radiology, Cincinnati Children s Hospital, Cincinnati, OH, USA
    Pediatr Radiol 41:1057-60. 2011
    ..Pre- and postnatal imaging, as well as clinical follow-up, demonstrate the rapid regression of both the intracranial and cutaneous portions of this lesion during the first year of life...
  16. doi request reprint Spectrum of hepatic hemangiomas: management and outcome
    Belinda Dickie
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45236, USA
    J Pediatr Surg 44:125-33. 2009
    ..Infants with multiple cutaneous hemangiomas often present with hepatic hemangiomas. They can follow a benign clinical course or require complex management. We reviewed our experience in the management of hepatic hemangiomas...
  17. ncbi request reprint Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine
    Camille Haisley-Royster
    Duke University Medical Center, Durham, NC, USA
    J Pediatr Hematol Oncol 24:459-62. 2002
    ..The syndrome develops in infancy and is associated with a high morbidity and mortality rate. The purpose of this study was to assess the effectiveness of vincristine in the treatment of KMP...